LIFE SCIENCES + HEALTHCARE OUTLOOK IN 2022 When the J.P. Morgan Healthcare Conference took place last January, I skipped it, optimistically thinking that things would be different and safer the following year. Shortly before this year’s conference, it was announced...
Whatever you call it, The Great…Resignation, Reshuffle, Reset, etc., people are leaving the “devil they know for the devil they don’t” more than I’ve seen in over twenty years of working in executive search. I’ve heard just about every scenario as to why an executive...
2021 brought about a massive groundswell of executive-level search activity, caused by the perfect storm of market factors — a nearly immediate halt of economic activity, followed by a rapid rebound, and a shift in leadership competencies needed to succeed in our new...
We recently closed the chapter that was 2021, a second year of dealing with a global pandemic and the uncertainty of the new variants that arose. We saw record stock market runs, enormous transaction activity for PE firms, and an economy that rose and recovered from...
Ringing in the New Year As we slowly emerge from the pandemic, we are beginning to see a bright spot in the future of the life sciences industry and wider global economy. From what I can gather, there is a collective and anticipatory sigh of relief that this will all...
WHO + WHY? Looking back at M+A activity this year, I took notice of a few that stood out, irrespective of their size. Over the past 12 months, companies have experienced an increase in IPOs. However, if this was used as their exit strategy, it means M+A is down....
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
